Vimian Group AB Overview
Pro stress-test →Vimian Group is a global animal health company built around four core business segments: Specialty Pharma (Nextmune), Diagnostics (Indical), Veterinary Services (VetFamily), and MedTech (Movora). The company serves veterinary professionals, laboratories, and pet owners across 80+ markets through innovation-driven businesses addressing niche veterinary healthcare needs.
Strategic Profile
Pro stress-test →Vimian operates a diversified, acquisition-driven model that consolidates fragmented veterinary solutions into an integrated platform with shared infrastructure and capital. The company leverages its network access to 17,000+ veterinary clinics and laboratories to drive organic growth while expanding through strategic acquisitions into specialized niches like veterinary dentistry.
Competitive Landscape
Pro stress-test →Vimian competes in the fragmented global animal health market against larger diversified pharma companies (e.g., Boehringer Ingelheim, Zoetis) as well as specialized regional players. Its advantage lies in consolidating multiple niche businesses under one platform, enabling cross-selling, operational synergies, and technology leverage that pure-play competitors cannot match.
Industry Context
Vimian Group AB operates in Animal Health / Veterinary Services & Diagnostics.
Key facts
Founded: 2020 · Headquarters: Stockholm, Sweden · Employees: 1,200 · Revenue: EUR 374.8M (2024) · Market cap: $1.67B